bpc-157 fda warning september 2025 Heal or Harm: Body Protective Compound-157 in the Gray Zone FDA to weigh easing limits
Description
It helps ensure safe and effective treatment
Importantly, Dihexa simultaneously increases expression of anti-inflammatory interleukin-10 (IL-10), suggesting the peptide actively shifts the neuroinflammatory balance toward resolution rather than simply suppressing inflammation
F.WangL
It usually produces less weight loss than tirzepatide, but it has the longest outcomes record in the class: fewer cardiovascular events, slower kidney decline, and years of diabetes-trial safety data
